Aboca Spa Societa' Agricola
16
0
0
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
25%
4 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Oral Administration of Actitan-F in Paediatric Diarrhoea
Role: lead
Administration of a Natural Molecular Complex in Functional Chronic Constipation
Role: lead
Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.
Role: lead
Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS
Role: lead
ABO-GLYC in Type 2 Diabetes
Role: lead
Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population
Role: collaborator
Mipolixin® Compared to Poliprotect® in Moderate Functional Dyspepsia and Heartburn.
Role: lead
Efficacy of MEMORMAX in Subjects With MCI
Role: lead
Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months
Role: lead
Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea
Role: lead
Evaluation of Libramed in Obesity Treatment
Role: lead
Effectiveness & Safety of Neofitoroid® in Hemorrhoidal Disease
Role: lead
Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.
Role: collaborator
Policaptil Gel Retard® in Overweight and Mild Obese Subjects
Role: lead
Comparison of a Protective Cough Syrup Against Placebo on Night Cough in Children 1-5 Years Coughing Since 1- 2 Days Due to Common Cold
Role: collaborator
Evaluation of the Efficacy and Tolerability of ABO/MEG-B-09 in Children With Acute Cough
Role: lead
All 16 trials loaded